Joerg Thomalla

Praxis Hamatol & Onkol

关注

立即认领

关注

立即认领

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 22 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Baseline CD4+ and Expansion of Γδ T Cells Correlate with Response to Durvalumab in Triple‐negative Breast Cancer Patients

Chiara Massa,Thomas Karn,Karsten Weber,Andreas Schneeweiss,Claus Hanusch,Jens Uwe Blohmer,Dirk-Michael Zahm,Christian Jackisch,Marion van Mackelenbergh,Joerg Thomalla,Frederik Marme,Jens Huober,Volkmar Mueller,Christian Schem,Anja Mueller,Elmar Stickeler,Katharina Biehl,Peter A. Fasching,Michael Untch,Sibylle Loibl,Carsten Denkert,Barbara Seliger

Clinical and Translational Medicine（2024）

引用0浏览0WOS引用

CD8+ CD28− Regulatory T Cells after Induction Therapy Predict Progression-Free Survival in Myeloma Patients: Results from the GMMG-HD6 Multicenter Phase III Study

Katharina Kriegsmann, Gigi Nu Hoang Quy Ton,Mohamed H. S. Awwad,Axel Benner,Uta Bertsch,Britta Besemer,Mathias Haenel,Roland Fenk,Markus Munder,Jan Duerig,Igor W. Blau,Stefanie Huhn,Dirk Hose,Anna Jauch,Christoph Mann,Niels Weinhold,Christof Scheid,Roland Schroers,Ivana von Metzler,Aneta Schieferdecker,Joerg Thomalla,Peter Reimer,Rolf Mahlberg,Ullrich Graeven,Stephan Kremers,Uwe M. Martens,Christian Kunz,Manfred Hensel,Andrea Seidel-Glaetzer,Katja C. Weisel,Hans J. Salwender,Carsten Mueller-Tidow,Marc S. Raab,Hartmut Goldschmidt,Elias K. Mai,Michael Hundemer

Leukemia（2024）

引用0浏览0WOSNATURE引用

Immunological Subgroups Predicting Efficacy of Elotuzumab in Multiple Myeloma Patients: Insights from the GMMG-HD6 Clinical Trial

Gigi Nu Hoang Quy Ton,Katharina Kriegsmann,Mohamed H. S. Awwad,Axel Benner,Uta Bertsch,Britta Besemer,Mathias Haenel,Roland Fenk,Jana Schlenzka,Markus Munder,Jan Duerig,Igor Wolfgang Blau,Stefanie Huhn,Dirk Hose,Anna Jauch,Andreas Neubauer,Niels Weinhold,Christof Scheid,Roland Schroers,Ivana von Metzler,Aneta Schieferdecker,Joerg Thomalla,Peter Reimer,Rolf Mahlberg,Ullrich Graeven,Stephan Kremers,Uwe Martens,Christian Kunz,Manfred Hensel,Andrea Seidel-Glaetzer,Katja Weisel,Hans Salwender,Carsten Mueller-Tidow,Marc S. Raab,Hartmut Goldschmidt,Elias K. Mai,Michael Hundemer

BLOOD（2023）

引用0浏览0引用

Biomarkers for Response to Immunotherapy in Triple-Negative Breast Cancer: Differences Between Survival and Pcr Biomarkers

Carsten Denkert,Andreas Schneeweiss,Julia Rey,Thomas Karn,Michael Braun,Jens Bodo Huober,Hans-Peter Sinn,Dirk Michael Zahm,Claus Hanusch,Frederik Marme,Jenny Furlanetto,Joerg Thomalla,Jens U. Blohmer,Marion Van Mackelenbergh,Peter Staib,Christian Jackisch,Peter A. Fasching,Bruno Valentin Sinn,Michael Untch,Sibylle Loibl

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2022)

引用6浏览0引用

Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: an Exploratory Analysis of the GeparOcto Trial

Bernd Gerber,Andreas Schneeweiss,Volker Moebus,Michael Golatta,Hans Tesch,David Krug,Claus Hanusch,Carsten Denkert,Kristina Luebbe,Joerg Heil,Jens Huober,Beyhan Ataseven,Peter Klare,Markus Hahn,Michael Untch,Karin Kast,Christian Jackisch,Joerg Thomalla,Fenja Seither,Jens-Uwe Blohmer,Kerstin Rhiem,Peter A. Fasching,Valentina Nekljudova,Sibylle Loibl,Thorsten Kuehn

Cancers（2022）

引用19浏览0WOS引用

Elotuzumab in Combination with Lenalidomide, Bortezomib, Dexamethasone and Autologous Transplantation for Newly-Diagnosed Multiple Myeloma: Results from the Randomized Phase III GMMG-HD6 Trial

Hartmut Goldschmidt,Elias K. Mai,Uta Bertsch,Britta Besemer,Mathias Haenel,Kaya Miah,Roland Fenk,Jana Schlenzka,Markus Munder,Jan Duerig,Igor Wolfgang Blau,Stefanie Huhn,Dirk Hose,Anna Jauch,Christina Kunz,Andreas Neubauer,Christof Scheid,Roland Schroers,Ivana von Metzler,Aneta Schieferdecker,Joerg Thomalla,Peter Reimer,Rolf Mahlberg,Ullrich Graeven,Stephan Kremers,Uwe M. Martens,Christian Kunz,Manfred Hensel,Andrea Seidel-Glaetzer,Katja Weisel,Marc-Steffen Raab,Hans Salwender

Blood（2021）

引用23浏览0引用

Addition of Isatuximab to Lenalidomide, Bortezomib and Dexamethasone As Induction Therapy for Newly-Diagnosed, Transplant-Eligible Multiple Myeloma Patients: the Phase III GMMG-HD7 Trial

Hartmut Goldschmidt,Elias K. Mai,Eva Nievergall,Roland Fenk,Uta Bertsch,Diana Tichy,Britta Besemer,Jan Duerig,Roland Schroers,Ivana V. Metzler,Mathias Haenel,Christoph Mann,Anne-Marie Asemissen,Bernhard Heilmeier,Stefanie Huhn,Katharina Kriegsmann,Niels Weinhold,Steffen P. Luntz,Tobias A. W. Holderried,Karolin Trautmann-Grill,Deniz Gezer, Maika Klaiber-Hakimi, Martin Mueller,Cyrus Khandanpour,Wolfgang Knauf,Markus Munder,Thomas Geer,Hendrik Riesenberg,Joerg Thomalla,Martin Hoffmann,Marc-Steffen Raab,Hans Salwender,Katja Weisel

Blood（2021）

引用24浏览0引用

Durvalumab Improves Long-Term Outcome in TNBC: Results from the Phase II Randomized GeparNUEVO Study Investigating Neodjuvant Durvalumab in Addition to an Anthracycline/taxane Based Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC)

Sibylle Loibl,Andreas Schneeweiss,Jens Bodo Huober,Michael Braun,Julia Rey,Jens U. Blohmer,Jenny Furlanetto,Dirk Michael Zahm,Claus Hanusch,Joerg Thomalla,Christian Jackisch,Peter Staib,Theresa Link,Kerstin Rhiem,Christine Solbach,Peter A. Fasching,Nicole Burchardi,Carsten Denkert,Michael Untch

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用66浏览0引用

Differential Effect on Different Immune Subsets of Neoadjuvant Chemotherapy in Patients with TNBC

Chiara Massa,Thomas Karn,Carsten Denkert,Andreas Schneeweiss,Claus Hanusch,Jens-Uwe Blohmer,Dirk-Michael Zahm,Christian Jackisch,Marion van Mackelenbergh,Joerg Thomalla,Frederik Marme,Jens Huober,Volkmar Mueller,Christian Schem,Anja Mueller,Elmar Stickeler,Katharina Biehl,Peter A. Fasching,Michael Untch,Sibylle Loibl,Karsten Weber,Barbara Seliger

Journal for ImmunoTherapy of Cancer（2020）

引用20浏览0WOS引用

Survival Improvement of Patients with Chronic Lymphocytic Leukemia (CLL) in Routine Care 1995-2017

Rudolf Weide,Stefan Feiten,Geothy Chakupurakal,Vera Friesenhahn,Kristina Kleboth,Hubert Koeppler,Julia Lutschkin,Christoph van Roye,Joerg Thomalla,Jochen Heymanns

Leukemia & lymphoma/Leukemia and lymphoma（2019）

引用24浏览0WOS引用

加载更多

作者统计

#Papers: 22

#Citation: 470

H-Index: 12

G-Index: 18

Sociability: 5

Diversity: 2

Activity: 12

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn